For all of the quality care it delivers, the U.S. health care system is one of the most dysfunctional sectors of the U.S. economy. The government spends nearly 50 cents of every dollar spent on health care, most consumers are almost entirely insulated from the cost of their decisions, and employers decide what kind of health insurance their employees get.
But while the U.S. health care system begs for reform, the Patient Protection and Affordable Care Act only exacerbates all of the current problems, promising to devolve into a price-controlled system rationed and micromanaged by bureaucrats.
IPI believes there are much better options: reform the tax treatment of health insurance; remove the state and federal mandates and regulations that make coverage more expensive; pass medical liability reform; and promote policies that create value-conscious shoppers in the health care marketplace.
Here's A Drug-Industry Reform That Would Actual Lower Costs To Patients
It’s time to reform a system that costs patients, taxpayers, and the entire American health care system far more than it should. More transparency has a way of lowering costs for patients — and the country.
Eroding Patent Rights Threatens U.S. Cancer Patients
It's no exaggeration to say that a cure for cancer depends on strong patent protections. The Bayh-Dole system has worked remarkably well. Yet the Biden administration seeks to break what has never been broken.
Biden's Border Crisis Will Vastly Increase the Number of Uninsured
Millions of undocumented immigrants are crossing the border, which will vastly increase the number of uninsured in the country.
Obamacare: Costing Taxpayers More While Enjoying It Less
Obamacare proponents made a lot of promises to get the legislation passed. As many predicted, the results have fallen far short of the promises.
The Slippery Slope of Price Controls on Prescription Drugs
It's not about achieving fair prices, and never has been. It's about having the government dictate prices to a wide range of companies and industries. It's about control, not competition.
Comments to NIH Regarding Private Sector Investment in Prescription R&D
Adressing the importance of private sector investment in prescription drug research and development and its relationship to NIH funding.
The Doctor Can't See You Now--He's on Strike
If you want to see a doctor in England, get in line and wait.
If Obamacare's So Great, Why Limit Other Options?
Socialist misery loves company, which may be why Biden is trying to limit access to short-term health insurance coverage—again.
States Jump on the Prescription Drug Price-Control Bandwagon
Democrats in Washington think imposing prescription drug price controls is a political winner; so Democrats at the state level will try their hand.
Does Preventive Health Care Save Lives--or Money?
Obamacare mandated free preventive care for a wide range of services. That mandate may be on life support.
Total Records: 706
